The challenges of using blood-based miRNAs in the clinic

Tran, NT; Khoury, S

The challenges of using blood-based miRNAs in the clinic

Tran, NT

Khoury, S

Permalink

Citation:: 2019
Issue Date:: 2019

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published VersionAdobe PDF (228.16 kB)

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Tran, NT https://orcid.org/0000-0001-7747-2530	en_US
dc.contributor.author	Khoury, S https://orcid.org/0000-0001-5631-7478	en_US
dc.date.issued	2019	en_US
dc.identifier.citation	2019	en_US
dc.identifier.uri	http://hdl.handle.net/10453/126191
dc.description.abstract	This preprint addresses the enormous challenges confronting researchers invested in serum miRNAs and their potential use as clinical biomarkers. We discuss some of the inherent technical obstacles and suggest several possible solutions. We hope to encourage all researchers to be united and collaborative in the pursuit of delivering clinically relevant biomarkers in the near future.	en_US
dc.rights	info:eu-repo/semantics/openAccess
dc.title	The challenges of using blood-based miRNAs in the clinic	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Engineering and Information Technology
pubs.organisational-group	/University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
utslib.copyright.status	open_access	*

Abstract:

This preprint addresses the enormous challenges confronting researchers invested in serum miRNAs and their potential use as clinical biomarkers. We discuss some of the inherent technical obstacles and suggest several possible solutions. We hope to encourage all researchers to be united and collaborative in the pursuit of delivering clinically relevant biomarkers in the near future.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/126191